Recombinant multi-species Selenoprotein P/SELENOP protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Selenoprotein P/SELENOP protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a selenoprotein that is predominantly expressed in the liver and secreted into the plasma. This selenoprotein is unique in that it contains multiple selenocysteine (Sec) residues per polypeptide (10 in human), and accounts for most of the selenium in plasma. It has been implicated as an extracellular antioxidant, and in the transport of selenium to extra-hepatic tissues via apolipoprotein E receptor-2 (apoER2). Mice lacking this gene exhibit neurological dysfunction, suggesting its importance in normal brain function. Sec is encoded by the UGA codon, which normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, designated the Sec insertion sequence (SECIS) element, that is necessary for the recognition of UGA as a Sec codon, rather than as a stop signal. The mRNA for this selenoprotein contains two SECIS elements. The use of alternative polyadenylation sites, one located in between the two SECIS elements, results in two populations of mRNAs containing either both (predominant) or just the upstream SECIS element (PMID:27881738). Alternatively spliced transcript variants have also been found for this gene. [provided by RefSeq, Oct 2018]
The Alternative Names of target: D15Ucla1,SELENOP,SELP,SEPP,SEPP1,Se-P,SeP,Selenop,Selenoprotein P,Sepp1,selp
Go
to Selenoprotein P/SELENOP products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-SE0464-Ag-1/ GM-Tg-hg-SE0464-Ag-2 | Human Selenoprotein P/SELENOP protein | Human |
| GM-Tg-rg-SE0464-Ag-1/ GM-Tg-rg-SE0464-Ag-2 | Rat Selenoprotein P/SELENOP protein | Rat |
| GM-Tg-mg-SE0464-Ag-1/ GM-Tg-mg-SE0464-Ag-2 | Mouse Selenoprotein P/SELENOP protein | Mouse |
| GM-Tg-cynog-SE0464-Ag-1/ GM-Tg-cynog-SE0464-Ag-2 | Cynomolgus/Rhesus macaque Selenoprotein P/SELENOP protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-SE0464-Ag-1/ GM-Tg-felg-SE0464-Ag-2 | Feline Selenoprotein P/SELENOP protein | Feline |
| GM-Tg-cang-SE0464-Ag-1/ GM-Tg-cang-SE0464-Ag-2 | Canine Selenoprotein P/SELENOP protein | Canine |
| GM-Tg-bovg-SE0464-Ag-1/ GM-Tg-bovg-SE0464-Ag-2 | Bovine Selenoprotein P/SELENOP protein | Bovine |
| GM-Tg-equg-SE0464-Ag-1/ GM-Tg-equg-SE0464-Ag-2 | Equine Selenoprotein P/SELENOP protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-SE0464-Ag-1/ GM-Tg-hg-SE0464-Ag-2;
GM-Tg-rg-SE0464-Ag-1/ GM-Tg-rg-SE0464-Ag-2;
GM-Tg-mg-SE0464-Ag-1/ GM-Tg-mg-SE0464-Ag-2; GM-Tg-cynog-SE0464-Ag-1/ GM-Tg-cynog-SE0464-Ag-2; GM-Tg-felg-SE0464-Ag-1/ GM-Tg-felg-SE0464-Ag-2; GM-Tg-cang-SE0464-Ag-1/ GM-Tg-cang-SE0464-Ag-2; GM-Tg-bovg-SE0464-Ag-1/ GM-Tg-bovg-SE0464-Ag-2; GM-Tg-equg-SE0464-Ag-1/ GM-Tg-equg-SE0464-Ag-2 |
| Products Name | Selenoprotein P/SELENOP protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | Selenoprotein P/SELENOP |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Selenoprotein P/SELENOP protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.